AxCell to Conduct Pilot Study for Pluvita | GenomeWeb

NEW YORK, Dec. 11 - AxCell Biosciences said Tuesday it had agreed to run a pilot program for Pluvita to determine protein interactions based on signal transduction research.

Axcell said it would identify full-length peptides that bind to a compound Pluvita has earmarked for the research program. 

Financial and other terms of the agreement were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."